PGHH FY26 Results: Revenue at ₹4,290 Cr, PAT ₹857 Cr; Proposes ₹60 Final Dividend
Procter & Gamble Hygiene and Health Care Limited reported FY26 revenue of ₹4,290 crore and PAT of ₹857 crore, up 19%. The board recommended a final dividend of ₹60 per share. The 62nd AGM for FY26 is scheduled, with registration for speakers closing September 1, 2026. P&G Shiksha impacted over 1 crore children.
The announcement includes key financial results, dividend declaration, and details about the upcoming Annual General Meeting, all of which are material information for investors and stakeholders.
The company reported strong financial results with increased revenue and significant profit growth. The recommendation of a substantial dividend and positive updates on CSR initiatives contribute to a positive sentiment.
Procter & Gamble Hygiene and Health Care Limited (PGHH) announced its financial results for the fiscal year ended March 31, 2026. The company reported revenue from operations of ₹4,290 crore, a marginal increase compared to the previous year. Profit After Tax (PAT) saw a significant rise of 19% to ₹857 crore, driven by targeted productivity and efficiency interventions.
The company's Board of Directors has recommended a final dividend of ₹60 per equity share, subject to shareholder approval at the 62nd Annual General Meeting (AGM). This, along with an interim dividend of ₹195 per equity share declared earlier, brings the total dividend for FY26 to ₹255 per equity share.
PGHH also announced that the Annual Report and the Notice for the 62nd AGM, which will cover the Financial Year ended March 31, 2026, have been dispatched to shareholders on August 17, 2026. Shareholders wishing to express views or ask questions during the AGM can register as speakers by September 1, 2026.
The company highlighted its strategic focus on consumer-centric innovation, brand building, and go-to-market capabilities. Key product developments include upgrades to the Whisper Nights portfolio for enhanced comfort and protection, and the launch of Vicks Cough Syrup, a premium, non-drowsy formulation combining science and tradition. The ZzzQuil Natura Sleep Gummies were also upgraded with higher melatonin and ashwagandha.
In its CSR initiatives, P&G Shiksha has positively impacted over 1 crore children from underserved communities. The company's financial performance was underpinned by a disciplined execution of its integrated growth strategy, focusing on a strong product portfolio, superiority, productivity, constructive disruption, and an empowered organization.
What to do with a filing like this
Procter & Gamble Hygiene and Health Care Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Procter & Gamble Hygiene and Health Care Limited. Read the original for the full detail.